Relx (LON:REL) Rating Reiterated by Morgan Stanley

Relx (LON:REL – Get Rating)‘s stock had its “overweight” rating reiterated by equities research analysts at Morgan Stanley in a research report issued on Wednesday, Digital Look reports.

REL has been the subject of several other reports. Credit Suisse Group set a GBX 2,650 ($32.67) target price on shares of Relx in a report on Tuesday, April 19th. UBS Group set a GBX 2,615 ($32.24) price target on shares of Relx in a research report on Wednesday, March 2nd. JPMorgan Chase & Co. set a GBX 2,670 ($32.92) target price on shares of Relx in a research report on Thursday, April 21st. Berenberg Bank upped their target price on shares of Relx from GBX 2,300 ($28.36) to GBX 2,330 ($28.73) and gave the stock a “hold” rating in a research report on Friday, February 11th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Relx in a research note on Tuesday, February 8th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of GBX 2,440.42 ($30.09).

Shares of REL opened at GBX 2,300.34 ($28.36) on Wednesday. The firm’s 50-day moving average price is GBX 2,338.24 and its 200-day moving average price is GBX 2,317.55. The firm has a market capitalization of £44.33 billion and a price-to-earnings ratio of 30.35. The company has a current ratio of 0.63, a quick ratio of 0.47 and a debt-to-equity ratio of 191.50. Relx has a 1-year low of GBX 1,781 ($21.96) and a 1-year high of GBX 2,474 ($30.50).

In other news, insider N L. Luff sold 13,867 shares of the stock in a transaction on Friday, February 11th. The shares were sold at an average price of GBX 2,273 ($28.02), for a total value of £315,196.91 ($388,604.25).

About Relx (Get Rating)

RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.

Further Reading